doi: 10.3390/jcm13102841 86 SharmaRGuptaSAgarwalAHenkelRFinelliRParekhNet al
However, the profound weight loss observed with GLP-1 RA treatment (as well as other approaches resulting in weight loss through appetite suppression, such as bariatric surgery) raises some concerns
Morgan Research forecasts that the GLP-1 market will surpass $100 billion by 2030, with obesity treatments contributing over $40 billion
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management
[PubMed] [PMC] Mahdi C, Ajeng M, Sari M (2019) The effects goat milk yoghurt casein on malondialdehyde (MDA) level of rats ( Rattus norvegicus ) exposured by 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCCD)